Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Family Practice · MOUNT OLIVE, NC · NPI 1184706830
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 290 | 65 |
| Omeprazole | Omeprazole | 213 | 61 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 211 | 29 |
| Alprazolam | Alprazolam | 201 | 31 |
| Gabapentin | Gabapentin | 193 | 47 |
| Atorvastatin Calcium | Atorvastatin Calcium | 181 | 52 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 160 | 22 |
| Losartan Potassium | Losartan Potassium | 155 | 39 |
| Amlodipine Besylate | Amlodipine Besylate | 149 | 38 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 146 | 43 |
| Furosemide | Furosemide | 128 | 45 |
| Metformin Hcl | Metformin Hcl | 124 | 34 |
| Lisinopril | Lisinopril | 122 | 34 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 120 | 33 |
| Prednisone | Prednisone | 118 | 35 |
| Metoprolol Succinate | Metoprolol Succinate | 115 | 36 |
| Pantoprazole Sodium | Pantoprazole Sodium | 110 | 33 |
| Potassium Chloride | Potassium Chloride | 109 | 28 |
| Meloxicam | Meloxicam | 108 | 26 |
| Cefuroxime | Cefuroxime Axetil | 104 | 73 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 101 | 30 |
| Hydrochlorothiazide | Hydrochlorothiazide | 100 | 27 |
| Duloxetine Hcl | Duloxetine Hcl | 91 | 13 |
| Montelukast Sodium | Montelukast Sodium | 91 | 23 |
| Oxycodone Hcl | Oxycodone Hcl | 82 | 13 |
| Carvedilol | Carvedilol | 76 | 18 |
| Paroxetine Hcl | Paroxetine Hcl | 75 | 17 |
| Zolpidem Tartrate | Zolpidem Tartrate | 75 | 14 |
| Methylprednisolone | Methylprednisolone | 74 | 54 |
| Ezetimibe | Ezetimibe | 73 | 18 |
| Clopidogrel | Clopidogrel Bisulfate | 72 | 15 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 72 | 22 |
| Ozempic | Semaglutide | 71 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 60 | 12 |
| Allopurinol | Allopurinol | 59 | 18 |
| Azithromycin | Azithromycin | 59 | 43 |
| Temazepam | Temazepam | 59 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 58 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 57 | 17 |
| Pregabalin | Pregabalin | 55 | 13 |
| Tramadol Hcl | Tramadol Hcl | 54 | 18 |
| Eliquis | Apixaban | 48 | 12 |
| Sertraline Hcl | Sertraline Hcl | 48 | 12 |
| Escitalopram Oxalate | Escitalopram Oxalate | 45 | 15 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 45 | 15 |
| Mirtazapine | Mirtazapine | 45 | 13 |
| Tamsulosin Hcl | Tamsulosin Hcl | 45 | 14 |
| Clonazepam | Clonazepam | 44 | suppressed |
| Fluconazole | Fluconazole | 44 | 22 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 43 | 32 |
| Famotidine | Famotidine | 43 | 12 |
| Jardiance | Empagliflozin | 42 | suppressed |
| Memantine Hcl | Memantine Hcl | 42 | suppressed |
| Xarelto | Rivaroxaban | 41 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 40 | 12 |
| Promethazine Hcl | Promethazine Hcl | 40 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 38 | 12 |
| Synthroid | Levothyroxine Sodium | 38 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 36 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 35 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 33 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 33 | 21 |
| Hydrocortisone | Hydrocortisone | 33 | 14 |
| Levetiracetam | Levetiracetam | 33 | suppressed |
| Lorazepam | Lorazepam | 32 | suppressed |
| Celecoxib | Celecoxib | 31 | 13 |
| Diazepam | Diazepam | 31 | suppressed |
| Spironolactone | Spironolactone | 31 | 11 |
| Trulicity | Dulaglutide | 30 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 29 | suppressed |
| Simvastatin | Simvastatin | 29 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 29 | 21 |
| Glipizide Er | Glipizide | 28 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 27 | 16 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 27 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 26 | suppressed |
| Bupropion Xl | Bupropion Hcl | 26 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 26 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 25 | suppressed |
| Glipizide | Glipizide | 25 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 25 | suppressed |
| Octreotide Acetate | Octreotide Acetate | 25 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 25 | 12 |
| Citalopram Hbr | Citalopram Hydrobromide | 24 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 24 | suppressed |
| Ondansetron Odt | Ondansetron | 23 | 12 |
| Amoxicillin | Amoxicillin | 21 | 11 |
| Baclofen | Baclofen | 21 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 21 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 20 | suppressed |
| Januvia | Sitagliptin Phosphate | 20 | suppressed |
| Prempro | Estrogen,con/M-Progest Acet | 20 | suppressed |
| Ibu | Ibuprofen | 19 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 19 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 19 | 18 |
| Clonidine Hcl | Clonidine Hcl | 18 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 18 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 18 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 18 | suppressed |
| Mounjaro | Tirzepatide | 18 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 18 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 18 | suppressed |
| Cephalexin | Cephalexin | 17 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 17 | suppressed |
| Entresto | Sacubitril/Valsartan | 17 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 17 | 15 |
| Colchicine | Colchicine | 16 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 16 | suppressed |
| Methocarbamol | Methocarbamol | 16 | suppressed |
| Dexamethasone | Dexamethasone | 15 | suppressed |
| Valsartan | Valsartan | 15 | suppressed |
| Febuxostat | Febuxostat | 14 | suppressed |
| Fenofibrate | Fenofibrate | 14 | suppressed |
| Methadone Hcl | Methadone Hcl | 14 | suppressed |
| Methotrexate | Methotrexate Sodium | 14 | suppressed |
| Torsemide | Torsemide | 14 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 13 | suppressed |
| Fentanyl | Fentanyl | 13 | suppressed |
| Glimepiride | Glimepiride | 13 | suppressed |
| Leflunomide | Leflunomide | 13 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 13 | suppressed |
| Nitroglycerin | Nitroglycerin | 13 | suppressed |
| Risperidone | Risperidone | 13 | suppressed |
| Xeljanz Xr | Tofacitinib Citrate | 13 | suppressed |
| Atenolol | Atenolol | 12 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 12 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 12 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 12 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Gemfibrozil | Gemfibrozil | 12 | suppressed |
| Ibuprofen | Ibuprofen | 12 | suppressed |
| Lidocaine | Lidocaine | 12 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 12 | suppressed |
| Propylthiouracil | Propylthiouracil | 12 | suppressed |
| Sucralfate | Sucralfate | 12 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 12 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 11 | suppressed |
| Lansoprazole | Lansoprazole | 11 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error